• Exchange: Toronto
  • Sector: Health Care
  • Industry: Biotech & Pharma
  • Sub-Industry: Biotech

Cardiome Pharma Corp

+ Add to Watchlist

COM:CN

7.6600 CAD 0.2600 3.28%

As of 15:59:55 ET on 08/27/2014.

Snapshot for Cardiome Pharma Corp (COM)

Open: 7.8300 Day's Range: 7.6000 - 7.8400 Volume: 4,550
Previous Close: 7.9200 52wk Range: 2.0500 - 12.0200 1-Yr Rtn: +257.94%

Stock Chart for COM

No chart data available.
  • COM:CN 7.6600
  • 1D
  • 1M
  • 1Y
7.9200
Interactive COM Chart

Previous Close

No chart data available.
Interactive Chart
  • 1D
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Close:
Open:
High:
Low:
Volume:
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Key Statistics for COM

Current P/E Ratio (ttm) -
Estimated P/E(12/2014) -
Relative P/E vs. SPTSX -
Earnings Per Share (USD) (ttm) -1.3500
Est. EPS (USD) (12/2014) -0.6700
Est. PEG Ratio -
Market Cap (M CAD) 126.54
Shares Outstanding (M) 16.52
30 Day Average Volume 10,196
Price/Book (mrq) 3.6158
Price/Sale (ttm) 5.4142
Dividend Indicated Gross Yield -%
Cash Dividend -
Dividend Ex-Date
5 Year Dividend Growth -
Next Earnings Announcement 11/06/2014
mrq = Most Recent Quarter; ttm = Trailing Twelve Months

Income Statement for COM

  • Revenue
  • Net Income (M/USD)
  • Profit Margin (%)

Company Profile & Key Executives for COM

Cardiome Pharma Corp. is a product-focused cardiovascular drug development company with clinical drug programs. The Company's programs focus on atrial arrhythmia and congestive heart failure.

William L Hunter "Bill"President/CEOJennifer ArchibaldChief Financial Officer
Karim LaljiChief Commercial OfficerSheila M GrantChief Operating Officer
More Company Profile & Key Executives for COM

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

Sponsored Link
Advertisement
Advertisement
Sponsored Links
Advertisements
sec ||= nil